The Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association with Primary Response to EGFR-TKIs

被引：0
|
作者：
Liang, W. [1 ,2 ,3 ]
Li, C. [1 ,2 ,3 ]
Zhao, Y. [2 ,4 ,5 ]
He, J. [2 ,4 ,5 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Affiliated Hosp 1, Thorac Surg & Oncol, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR 19 Exon Deletion; EGFR 21 Exon L858R Mutation; Concomitant Mutations;
D O I：
10.1016/j.jtho.2018.08.442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA15.05
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [21] The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer
    Zhang, Yaxiong
    Chen, Gang
    Chen, Xi
    Fang, Wenfeng
    Gao, Fei
    Yang, Yunpeng
    Zhao, Yuanyuan
    Ma, Yuxiang
    Hong, Shaodong
    Zhang, Zhonghan
    Miao, Siyu
    Wu, Manli
    Huang, Xiaodan
    Luo, Youli
    Zhou, Cong
    Gong, Run
    Huang, Yan
    Chen, Likun
    Zhou, Ningning
    Zhao, Hongyun
    Zhang, Li
    JOURNAL OF CANCER, 2017, 8 (10): : 1865 - 1871
  • [22] Clinicopathologic differences between lung cancer with EGFR gene major (exon 19 deletions and exon 21 L858R) and other minor mutations
    Yamane, Y.
    Goto, K.
    Kenmotsu, H.
    Ohe, Y.
    Ohmatsu, H.
    Niho, S.
    Yoh, K.
    Ishii, G.
    Nagai, K.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Clinicopathological analysis between exon 19 deletion and L858R in EGFR-mutant completely resected lung adenocarcinoma
    Matsuzawa, Reiko
    Yoh, Kiyotaka
    Ishii, Genichiro
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Niho, Seiji
    Ohmatsu, Hironobu
    Tsuboi, Masahiro
    Goto, Koichi
    ANNALS OF ONCOLOGY, 2015, 26 : 84 - 84
  • [24] Comparison of the Efficacy of EGFR-TKIs Combined with Antiangiogenic Agents between Patients with Exon 19 Deletion and Patients with Exon 21 Leu858 Arg Mutation: A Systematic Review and Meta-Analysis
    Pan, Xin-Bin
    Liang, Fa-Song
    Tang, Qin-Yu
    Liang, Huan-Wei
    Zhu, Xiao-Dong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [25] Distinct Benefit of Overall Survival between Patients with Non-Small-Cell Lung Cancer Harboring EGFR Exon 19 Deletion and Exon 21 L858R Substitution
    Koyama, Nobuyuki
    Watanabe, Yasutaka
    Iwai, Yuki
    Kawamura, Rumi
    Miwa, Chihiro
    Nagai, Yoshiaki
    Hagiwara, Koichi
    Koyama, Shinichiro
    CHEMOTHERAPY, 2017, 62 (03) : 151 - 158
  • [26] Immunohistochemical Localization of Wild- type EGFR, E746-A750 Frame Deletion in Exon 19, and L858R Point Mutation in Exon 21 in Triple- negative Breast Cancer
    Vora, Hemangini H.
    Patel, Nupur A.
    Thakore, Prushin M.
    Shukla, Shilin N.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (09) : 653 - 660
  • [27] Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation
    Gilardone, Sophia
    Thapa, Ram
    Laborde, Jose
    Shafique, Michael
    Saltos, Andreas
    Creelan, Ben
    Tanvetyanon, Tawee
    Chiappori, Alberto
    Simon, George
    Haura, Eric B.
    Gray, Jhanelle E.
    Chen, Dung-Tsa
    Melzer, Daniel
    Pellini, Bruna
    JOURNAL OF THORACIC DISEASE, 2023, 15 (11) : 6115 - +
  • [28] Immunotherapy efficacy between exon 19 deletion and exon 21 L858R mutation in advanced EGFR mutant non-small-cell lung cancer: a direct and indirect meta-analysis
    Chen, Zihong
    Pang, Lanlan
    Yang, Yuwen
    He, Xinyi
    Zhan, Jianhua
    Zhang, Lin
    Xiong, Kangqiao
    Fang, Wenfeng
    Zhang, Li
    Zhang, Yaxiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02)
  • [29] CLINICOPATHOLOGIC DIFFERENCES BETWEEN LUNG CANCER WITH EGFR GENE MAJOR MUTATIONS (EXON 19 DELETIONS AND EXON 21 L858R) AND OTHER MINOR MUTATIONS
    Yamane, Y.
    Goto, K.
    Kenmotsu, H.
    Ohe, Y.
    Ohmatsu, H.
    Niho, S.
    Yoh, K.
    Ishii, G.
    Nagai, K.
    Nishiwaki, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 150 - 150
  • [30] Detecting EGFR exon 19 deletions and L858R in patients with non small cell lung cancer
    Hammoudeh, Z. A.
    Koleva, V.
    Kyuchukov, Y.
    Dakova, P.
    Penev, A.
    Minchev, T.
    Toncheva, D.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 582 - 582
12345